Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine to reduce alfentanil requirement during colonoscopy sedation in inflammatory bowel disease
NL-OMON44265Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in inflammatory bowel disease (IBD) comparing Lidocaine arm with Placebo arm (2 arms). Primary endpoint: Alfentanil requirement during colonoscopy. Started Nov 2016; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON44265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44265.